Tocqueville Asset Management L.P. Eiger Bio Pharmaceuticals, Inc. Transaction History

Tocqueville Asset Management L.P.

$6.27 Billion
Q3 2024

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 12, 2024	SELL	$0.21 - $0.43 $2,887 - $5,912	-13,750 Reduced 26.92%	37,325 $8,000
Q4 2022 Feb 09, 2023	SELL	$1.02 - $7.48 $20,910 - $153,340	-20,500 Reduced 28.64%	51,075 $60,000
Q3 2022 Nov 10, 2022	BUY	$6.04 - $9.66 $54,360 - $86,940	9,000 Added 14.38%	71,575 $539,000
Q2 2022 Aug 12, 2022	BUY	$4.99 - $8.96 $3,992 - $7,168	800 Added 1.3%	62,575 $394,000
Q1 2022 May 16, 2022	BUY	$3.84 - $9.74 $10,368 - $26,298	2,700 Added 4.57%	61,775 $513,000
Q4 2021 Feb 14, 2022	BUY	$5.12 - $8.19 $3,840 - $6,142	750 Added 1.29%	59,075 $307,000
Q3 2021 Nov 15, 2021	BUY	$6.68 - $9.1 $42,752 - $58,240	6,400 Added 12.33%	58,325 $390,000
Q2 2021 Aug 16, 2021	SELL	$7.82 - $9.23 $7,820 - $9,230	-1,000 Reduced 1.89%	51,925 $442,000
Q1 2021 May 17, 2021	SELL	$8.44 - $12.66 $101,280 - $151,920	-12,000 Reduced 18.48%	52,925 $468,000
Q4 2020 Feb 16, 2021	SELL	$7.98 - $12.29 $41,895 - $64,522	-5,250 Reduced 7.48%	64,925 $798,000
Q3 2020 Nov 16, 2020	BUY	$7.96 - $12.42 $65,272 - $101,844	8,200 Added 13.23%	70,175 $571,000
Q2 2020 Aug 12, 2020	BUY	$5.4 - $13.37 $25,650 - $63,507	4,750 Added 8.3%	61,975 $595,000
Q1 2020 May 15, 2020	BUY	$4.91 - $14.7 $31,178 - $93,345	6,350 Added 12.48%	57,225 $389,000
Q4 2019 Jan 14, 2020	BUY	$9.77 - $15.66 $143,619 - $230,202	14,700 Added 40.64%	50,875 $758,000
Q3 2019 Oct 31, 2019	BUY	$9.59 - $12.0 $18,460 - $23,100	1,925 Added 5.62%	36,175 $371,000
Q2 2019 Jul 31, 2019	BUY	$9.54 - $14.96 $100,169 - $157,080	10,500 Added 44.21%	34,250 $363,000
Q1 2019 Apr 30, 2019	SELL	$10.31 - $14.38 $26,806 - $37,388	-2,600 Reduced 9.87%	23,750 $332,000
Q4 2018 Feb 08, 2019	BUY	$8.63 - $12.4 $81,553 - $117,180	9,450 Added 55.92%	26,350 $268,000
Q3 2018 Nov 13, 2018	BUY	$9.6 - $12.9 $162,240 - $218,010	16,900 New	16,900 $203,000

Others Institutions Holding EIGR

# of Institutions

Shares Held

748K

Call Options Held

Put Options Held

View Full List

About Eiger BioPharmaceuticals, Inc.

Ticker EIGR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 43,966,800
Market Cap $76.1M
Description
Eiger BioPharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of targeted therapies for rare and ultra-rare diseases in the United States and internationally. Its lead product candidate is Lonafarnib, an orally bioavailable, small molecule, which is in Phase III clinical trials to ...

More about EIGR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Tocqueville Asset Management L.P., based on Form 13F filings with the SEC.

News

Stay updated on Tocqueville Asset Management L.P. with notifications on news.

Account